Skip to main content

Medications & Treatments

Follow Medications & Treatments in the Factlen app and get an alert when there is news. Get the app

More in Medications & Treatments

Multiple MyelomaEuropean Medicines Agency

EMA Backs Talquetamab and Daratumumab Combination for Second-Line Multiple Myeloma

Clinical Investigators 40%Pharmaceutical Industry 35%Regulatory Bodies 25%

5 sources · 2d ago

Cancer ImmunotherapyU.S. Food and Drug Administration

FDA Approves Jemperli Immunotherapy to Treat Rectal Cancer Without Surgery or Chemotherapy

Clinical Researchers 40%Regulatory Authorities 30%Industry & Market Analysts 30%

7 sources · 3d ago

ExplainerJoint Degeneration

Why Corticosteroid Injections Accelerate Knee Cartilage Loss Despite Relieving Osteoarthritis Pain

Orthopedic Surgeons 40%Pain Management Specialists 35%Regenerative Medicine Researchers 25%

4 sources · 4d ago

ExplainerWound Care

How Occlusive Dressings Double Skin Healing Speed by Allowing Cells to Bypass Scab Formation

Clinical Wound Specialists 50%Infection Control Researchers 30%Traditional First Aid Practitioners 20%

9 sources · 9d ago

ExplainerStatin Intolerance

Placebo-Controlled Crossover Trials Trace 90 Percent of Statin Muscle Pain to the Nocebo Effect

Clinical Trial Researchers 45%Cardiovascular Clinicians 35%Allergy and Immunology Specialists 20%

8 sources · 14d ago

ExplainerPharmacokinetics

Taking Proton Pump Inhibitors 30 to 60 Minutes Before Meals Synchronizes Peak Blood Levels With Food-Stimulated H+/K+-ATPase Pumps

Pharmacological Consensus 60%Clinical Practitioners 30%Pharmaceutical Developers 10%

4 sources · 20d ago

ExplainerHemodialysis Tech

How Hemodialysis Uses Countercurrent Flow and a Semipermeable Membrane to Clear Uremic Toxins

Clinical Nephrologists 35%Uremic Toxicity Researchers 35%Biomedical Engineers 30%

7 sources · 31d ago

ExplainerReceptor Mechanics

How Benzodiazepines Increase Chloride Ion Flux by Positive Allosteric Modulation of the GABA-A Receptor

Clinical Pharmacologists 35%Addiction Medicine Specialists 35%Structural Biologists 30%

9 sources · 36d ago

Lung CancerClinical Trial

Novel Targeted Therapy Zidesamtinib Achieves 94% Response Rate in Pivotal Trial for ROS1-Positive Lung Cancer

Clinical Researchers 40%Patient Advocates 35%Pharmaceutical Industry 25%

5 sources · 30d ago

ExplainerGut-Brain Axis

How Dopamine Dysregulation in the Enteric Nervous System Links ADHD to Chronic Gastrointestinal Disorders

Neurogastroenterologists 40%Psychiatric Researchers 35%Microbiome Specialists 25%

4 sources · 42d ago

ExplainerNSAID Pharmacology

How COX-1 and COX-2 Enzyme Selectivity Dictates the Pain Relief and Heart Risks of NSAIDs

Cardiovascular Risk Analysts 40%Gastroenterology Specialists 35%Pain Management Clinicians 25%

9 sources · 47d ago

ExplainerChronic Pain

Comparing the Evidence Behind Non-Drug Therapies for Chronic Low Back Pain

Evidence-Based Clinicians 40%Patient Advocates 30%Integrative Therapy Advocates 30%

10 sources · 52d ago

ExplainerGastric Cancer

FDA Approves Dual-Targeted Therapy for HER2-Positive Gastric Cancer First-Line Treatment

Clinical Oncologists 40%Regulatory Authorities 30%Medical Analysts 30%

4 sources · 57d ago

ExplainerCardiac Regeneration

Stem Cell Therapy Reverses Severe Heart Failure in 90% of Patients in Landmark Phase 2 Trial

Clinical Researchers 40%Cardiac Electrophysiologists 35%Healthcare Economists 25%

5 sources · 63d ago

Multiple Myeloma

U.S. FDA Approves Zenbexus, First-in-Class CELMoD Therapy, for Relapsed Multiple Myeloma

Clinical Oncologists 40%Regulatory & Trial Experts 35%Health Economists 25%

8 sources · 68d ago

Type 1 DiabetesMedical Breakthrough

FDA Approves First Drug to Preserve Insulin Production After Type 1 Diabetes Diagnosis

Pediatric Endocrinologists 47%Patient Advocacy Groups 35%Regulatory Watchdogs 18%

6 sources · 80d ago

Obesity Care

FDA Approves First Oral, Non-Peptide GLP-1 for Obesity, Ending Need for Fasting

Clinical Endocrinologists 41%Pharmaceutical Manufacturers 29%Patient Access Advocates 29%

7 sources · 80d ago

Thyroid Eye Disease

FDA Approves Lumvoa, First IGF-1R Inhibitor to Treat Thyroid Eye Disease

Clinical Ophthalmologists 35%Patient Advocacy Groups 35%Industry Analysts 30%

2 sources · 111d ago

PROTAC Therapies

FDA Approves Veppanu, the First 'Protein Degrader' Therapy for Advanced Breast Cancer

Clinical Oncologists 40%Biotech Analysts 30%Patient Advocates 30%

5 sources · 119d ago

ExplainerWomen's Health

Why Paracetamol Fails to Treat Menstrual Cramps Driven by Prostaglandins

Medical Consensus 45%Patient Advocates 35%Consumer Behavior Analysis 20%

5 sources · 130d ago

InjuryPDC ProTour

Prioritizing Health Over the Oche: Darts Stars Step Back to Heal Amid Grueling 2026 Schedule

Player Welfare Advocates 40%Tournament Analysts 30%Medical & Recovery Experts 30%

3 sources · 136d ago

InjuryDiamond League

Athletics Injury Report: Stars Target Diamond League Returns Ahead of Tokyo World Championships

Rehabilitating Athletes 45%Emerging Contenders 30%National Federations 25%

1 sources · 137d ago

Deep DiveGene Therapy

First Gene Therapy for Congenital Deafness Secures FDA Approval Following Landmark Clinical Trials

Clinical Researchers 44%Regulatory Agencies 28%Biotech Industry 28%

5 sources · 137d ago

ExplainerGenetic Medicine

A Single Infusion is Restoring Hearing in Deaf Children for Years

Clinical Geneticists 45%Deaf Community Advocates 30%Regulatory Bodies 25%

2 sources · 137d ago

ExplainerOncology Breakthrough

How mRNA Cancer Vaccines Are Turning the Immune System Into a Precision Weapon

Clinical Oncologists 40%Immunology Researchers 35%Biotech Innovators 25%

6 sources · 137d ago

Deep DiveTreatment Efficacy

Antidepressants vs. Therapy for Depression: What the Clinical Evidence Shows

Medical Consensus 44%Psychotherapy Advocates 33%Pharmacotherapy Proponents 22%

5 sources · 137d ago

ExplainerObesity Treatment

GLP-1s vs. Diet and Exercise: The Evidence-Based Guide to Weight Loss Trade-Offs

Medical Consensus 40%Lifestyle & Longevity Advocates 35%Patient Experience 25%

3 sources · 137d ago

InjuryTour de France

Cycling Stars Return from Injury Ahead of Tour de France Proving Ground

Recovering Riders 40%Team Management 35%Cycling Analysts 25%

3 sources · 137d ago

InjuryIndyCar

Romain Grosjean Cleared for Gateway IndyCar Race Just Days After Hand Surgery

Driver & Team Camp 40%Medical & Safety Officials 30%Neutral Analysts 30%

2 sources · 137d ago

InjurySuper Rugby

Super Rugby Playoffs Spark Major Injury Returns as All Blacks Navigate Captain's Setback

Club Management 35%National Team Selectors 35%Players & Medical Staff 30%

2 sources · 137d ago

AnalysisGLP-1 Microdosing

The Rise of 'Microdosing' GLP-1 Medications: Wellness Trend or Medical Risk?

Metabolic Optimizers 40%Clinical Skeptics 35%Access Advocates 25%

2 sources · 144d ago

InjuryWorld Rowing Cup

Fintan McCarthy's Bold Openweight Comeback Highlights Rowing's Evolution in Injury Rehab

Sports Medicine & Physiotherapy 55%Competitive Rowing Analysts 45%

7 sources · 136d ago

InjuryWorld Table Tennis

Table Tennis Injury Report: Pitchford and Ni Xialian Headline Remarkable Mid-Season Returns

Sports Medicine & Rehabilitation 40%Veteran Athlete Resilience 35%National Team Management 25%

3 sources · 136d ago

InjuryWorld Fencing Championships

The Road Back to the Piste: Major Fencing Comebacks Headline the 2026 World Championships

Returning Athletes 40%Medical & Sports Science Community 35%Coaches & Trainers 25%

5 sources · 136d ago